Cargando…
RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case Report
Uterine leiomyosarcoma (UL) is a rare malignant tumor that develops from the uterine smooth muscle tissue. Due to the low frequency and lack of sufficient data from clinical trials there is currently no effective treatment that is routinely accepted for UL. Here we report a case of a 65-years-old fe...
Autores principales: | Seryakov, Alexander, Magomedova, Zaynab, Suntsova, Maria, Prokofieva, Anastasia, Rabushko, Elizaveta, Glusker, Alexander, Makovskaia, Lyudmila, Zolotovskaia, Marianna, Buzdin, Anton, Sorokin, Maxim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435728/ https://www.ncbi.nlm.nih.gov/pubmed/34527573 http://dx.doi.org/10.3389/fonc.2021.666001 |
Ejemplares similares
-
RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual Biosamples
por: Sorokin, Maxim, et al.
Publicado: (2021) -
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
por: Sorokin, Maxim, et al.
Publicado: (2022) -
Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022) -
Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
por: Zolotovskaia, Marianna A., et al.
Publicado: (2019) -
Clinically relevant fusion oncogenes: detection and practical
implications
por: Sorokin, Maksim, et al.
Publicado: (2022)